EUVIMEDEUVIMED entdecken
Leitlinie

Italian guidelines for the management of irritable bowel syndrome

Giovanni Barbara, Cesare Cremon, Massimo Bellini, Maura Corsetti, Giovanni Di Nardo, Francesca Falangone, Lorenzo Fuccio, Francesca Galeazzi, Paola Iovino, Giovanni Sarnelli, Edoardo Vincenzo Savarino, Vincenzo Stanghellini und 8 weitere

Digestive and Liver Disease · 2023-02 · 55 (2) · 187-207

DOI: 10.1016/j.dld.2022.11.015 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Digestive and Liver Disease, 2023-02. Verfasst von Giovanni Barbara und 19 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Azienda Ospedaliero Universitaria di Bologna, 40126 Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, 40126 B…. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Gastroenterology, Gastroenterologists, Pediatrics. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 221 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The irritable bowel syndrome (IBS) is a chronic disorder of gut-brain interaction. IBS is still associated with areas of uncertainties, especially regarding the optimal diagnostic work-up and the more appropriate management. Experts from 7 Italian Societies conducted a Delphi consensus with literature summary and voting process on 27 statements. Recommendations and quality of evidence were evaluated using the grading of recommendations, assessment, development, and evaluation (GRADE) criteria. Consensus was defined as >80% agreement and reached for all statements. In terms of diagnosis, the consensus supports a positive diagnostic strategy with a symptom-based approach, including the psychological comorbidities assessment and the exclusion of alarm symptoms, together with the digital rectal examination, full blood count, C-reactive protein, serology for coeliac disease, and fecal calprotectin assessment. Colonoscopy should be recommended in patients with alarm features. Regarding treatment, the consensus strongly supports a dietary approach for patients with IBS, the use of soluble fiber, secretagogues, tricyclic antidepressants, psychologically directed therapies and, only in specific IBS subtypes, rifaximin. A conditional recommendation was achieved for probiotics, polyethylene glycol, antispasmodics, selective serotonin reuptake inhibitors and, only in specific IBS subtypes, 5-HT3 antagonists, 5-HT4 agonists, bile acid sequestrants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeGastroenterologyGastroenterologistsPediatricsHumansChildConsensusEndoscopy, GastrointestinalItaly

Stichwörter der Autor:innen

ConstipationDiarrheaDisorders of gut-brain interactionIrritable bowel syndrome

Autor:innen und Institutionen

  • IRCCS Azienda Ospedaliero Universitaria di Bologna, 40126 Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, Italy. Electronic address: giovanni.barbara@unibo.it.
  • IRCCS Azienda Ospedaliero Universitaria di Bologna, 40126 Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, Italy.
  • Gastrointestinal Unit, Department of Translational Sciences and New Technologies in Medicine and Surgery, University of Pisa, 56010 Pisa, Italy.
  • NIHR Nottingham Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingha…
  • NESMOS Department, Faculty of Medicine and Psychology, Sapienza University of Rome, Sant'Andrea University Hospital, Rome, Italy.
  • Medical-Surgical Department of Clinical Sciences and Translational Medicine, University Sapienza, Rome, Italy.

Zitieren

APA

Barbara, G., Cremon, C., Bellini, M., Corsetti, M., Di Nardo, G., Falangone, F., Fuccio, L., Galeazzi, F., Iovino, P., Sarnelli, G., Savarino, E. V., Stanghellini, V., Staiano, A., Stasi, C., Tosetti, C., Turco, R., Ubaldi, E., Zagari, R. M., Zenzeri, L., & Marasco, G. (2023). Italian guidelines for the management of irritable bowel syndrome. Digestive and Liver Disease, 55(2), 187-207. https://doi.org/10.1016/j.dld.2022.11.015

Vancouver

Barbara G, Cremon C, Bellini M, Corsetti M, Di Nardo G, Falangone F, et al. Italian guidelines for the management of irritable bowel syndrome. Digestive and Liver Disease. 2023;55(2):187-207. doi:10.1016/j.dld.2022.11.015

BibTeX
@article{Barbara2023,
  author = {Barbara, Giovanni and Cremon, Cesare and Bellini, Massimo and Corsetti, Maura and Di Nardo, Giovanni and Falangone, Francesca and Fuccio, Lorenzo and Galeazzi, Francesca and Iovino, Paola and Sarnelli, Giovanni and Savarino, Edoardo Vincenzo and Stanghellini, Vincenzo and Staiano, Annamaria and Stasi, Cristina and Tosetti, Cesare and Turco, Rossella and Ubaldi, Enzo and Zagari, Rocco Maurizio and Zenzeri, Letizia and Marasco, Giovanni},
  title = {Italian guidelines for the management of irritable bowel syndrome},
  journal = {Digestive and Liver Disease},
  year = {2023},
  volume = {55},
  number = {2},
  pages = {187--207},
  doi = {10.1016/j.dld.2022.11.015}
}
Kostenlos starten →